Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 3, 2015, Pages 933-939

  Chen, Ying ^a,b   Zhang, Lei ^a,b   Liu, Wen Xin ^a   Liu, Xiang Yu ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

Anemia; Epithelial ovarian cancer; Leukocytosis; Prognosis; Thrombocytosis

Indexed keywords

HEMOGLOBIN;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANEMIA; BLOOD; CANCER STAGING; CHINA; CYSTADENOCARCINOMA, SEROUS; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTOSIS; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; OVARIAN NEOPLASMS; PATHOLOGY; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY; SURVIVAL RATE; THROMBOCYTOSIS; YOUNG ADULT;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANEMIA; CHINA; CYSTADENOCARCINOMA, SEROUS; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; LEUKOCYTOSIS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOCYTOSIS; YOUNG ADULT;

EID: 84929305602     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.3.933     Document Type: Article

References (37)

1. Acs G, Xu X, Chu C, Acs P, Verma A (2004). Prognostic significance of erythropoietin expression in human endometrial carcinoma. Cancer, 100, 2376-86.
2. Akl EA, van Doormaal FF, Barba M, et al (2007). Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation. Cochrane Database Syst Rev, 18, CD006652.
3. Antonioli L, Blandizzi C, Pacher P, Hasko G (2013) Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer, 13, 842-57.
4. Ashour AA, Verschraegen CF, Kudelka AP, Kavanagh JJ (1997). Paraneoplastic syndromes of gynecologic neoplasms. J Clin Oncol, 15, 1272-82.
5. Burger RA (2011). Overview of anti-angiogenic agents in development for ovarian cancer. Gynecol Oncol, 121, 230-8.
6. Cao Y, Liu Q (2007). Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis. Adv Cancer Res, 97, 203-24.
7. Cho MS, Bottsford-Miller J, Vasquez HG, et al (2012). Platelets increase the proliferation of ovarian cancer cells. Blood, 120, 4869-72.
8. Cordella C, Luebbers HT, Rivelli V, Gratz KW, Kruse AL (2011). An evaluation of the preoperative hemoglobin level as a prognostic factor for oral squamous cell carcinoma. Head Neck Oncol, 3, 35.
9. Cullis J. (2013). Anaemia of chronic disease. Clin Med, 13, 193-6.
10. Dicato M, Plawny L, Diederich M (2010). Anemia in cancer. Ann Oncol, 21, 167-72.
11. Gastl G, Plante M, Finstad CL, et al (1993). High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol, 83, 433-41.
12. Gavalas NG, Liontos M, Trachana SP, et al (2013). Angiogenesis-related pathways in the pathogenesis of ovarian cancer. Int J Mol Sci, 14, 15885-909.
13. Gerestein CG, Eijkemans MJ, de Jong D, et al (2009). The prediction of progression-free and overall survival in women with an advanced stage of epithelial ovarian carcinoma. BJOG, 116, 372-80.
14. Grivennikov SI, Greten FR, Karin M (2010). Immunity, inflammation, and cancer. Cell, 140, 883-99.
15. Gungor T, Kanat-Pektas M, Sucak A, Mollamahmutoglu L (2009). The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors. Arch Gynecol Obstet, 279, 53-6.
16. Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74.
17. Hardee ME, Arcasoy MO, Blackwell KL, Kirkpatrick JP, Dewhirst MW (2006). Erythropoietin biology in cancer. Clin Cancer Res, 12, 332-9.
18. Herzog TJ, Vermorken JB, Pujade-Lauraine E, et al (2011). Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study. Gynecol Oncol, 122, 350-5.
19. Holgersson G, Sandelin M, Hoye E, et al (2012). Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer. Med Oncol, 29, 3176-82.
20. Jung MR, Park YK, Jeong O, et al (2011). Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol, 104, 504-10.
21. Khorana AA (2009). Cancer and thrombosis: implications of published guidelines for clinical practice. Ann Oncol, 20, 1619-30.
22. Li FX, Wei LJ, Zhang H, Li SX, Liu JT (2014). Significance of thrombocytosis in clinicopathologic characteristics and prognosis of gastric cancer. Asian Pac J Cancer Prev, 15, 6511-7.
23. Mabuchi S, Matsumoto Y, Isohashi F, et al (2011). Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer. Gynecol Oncol, 122, 25-32.
24. Mroczko B, Groblewska M, Wereszczynska-Siemiatkowska U, et al (2007). Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin Chim Acta, 380, 208-12.
25. Njolstad TS, Engerud H, Werner HM, Salvesen HB, Trovik J (2013). Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol, 131, 410-5.
26. Pelosof LC, Gerber DE (2010). Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc, 85, 838-54.
27. Qiu MZ, Xu RH, Ruan DY, et al (2010). Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumour Biol, 31, 633-41.
28. Qiu MZ, Yuan ZY, Luo HY, et al. (2010). Impact of pretreatment hematologic profile on survival of colorectal cancer patients. Tumour Biol, 31, 255-60.
29. Seo KH, Lee HS, Jung B, et al (2004). Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor-kappaB activation. Cancer Res, 64, 6482-8.
30. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
31. Stone RL, Nick AM, McNeish IA, et al (2012). Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med, 366, 610-8.
32. Tomita M, Shimizu T, Hara M, Ayabe T, Onitsuka T (2008). Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients. Anticancer Res, 28, 1947-50.
33. Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42.
34. van Rossum AP, Vlasveld LT, Vlasveld IN, et al (2009) Granulocytosis and thrombocytosis in renal cell carcinoma: a pro-inflammatory cytokine response originating in the tumour. Neth J Med, 67, 191-4.
35. Weiss G, Goodnough LT (2005). Anemia of chronic disease. N Engl J Med, 352, 1011-23.
36. Wheler J, Tsimberidou AM, Hong D, et al (2009). Survival of patients in a phase 1 clinic: the M.D. Anderson Cancer Center experience. Cancer, 115, 1091-9.
37. Yasuda Y, Fujita Y, Masuda S, et al (2002). Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs. Carcinogenesis, 23, 1797-805.